The estimated Net Worth of Boots Alliance, Inc.Och Us ... is at least $1.18 milliard dollars as of 1 March 2023. Boots Us owns over 15,475,166 units of Option Care Health stock worth over $349,333,560 and over the last 2 years Boots sold OPCH stock worth over $832,007,530.
Boots has made over 2 trades of the Option Care Health stock since 2022, according to the Form 4 filled with the SEC. Most recently Boots sold 15,475,166 units of OPCH stock worth $468,897,530 on 1 March 2023.
The largest trade Boots's ever made was selling 15,475,166 units of Option Care Health stock on 1 March 2023 worth over $468,897,530. On average, Boots trades about 13,237,583 units every 99 days since 2022. As of 1 March 2023 Boots still owns at least 10,771,926 units of Option Care Health stock.
You can see the complete history of Boots Us stock trades at the bottom of the page.
Over the last 5 years, insiders at Option Care Health have traded over $6,426,460,535 worth of Option Care Health stock and bought 202,320 units worth $5,246,552 . The most active insiders traders include Timothy P Sullivan, Elizabeth Quadros Betten et Dearborn Partners Llcmadiso.... On average, Option Care Health executives and independent directors trade stock every 28 days with the average trade being worth of $157,254,886. The most recent stock trade was executed by R Carter Pate on 3 September 2024, trading 1,465 units of OPCH stock currently worth $47,422.
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; infusion therapies for bleeding disorders; therapies that women need to survive and thrive through high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.
Option Care Health executives and other stock owners filed with the SEC include: